Market-Moving News for September 12th
Market-Moving News for September 12th
CSBR: 59% | Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. Also, Craig-Hallum upgraded the stock from Hold to Buy and maintained its $6 price target.
CSBR：59％ | Champions Oncology公佈的第一季度財務業績好於預期後，該公司股價走高。此外，Craig-Hallum將該股從持有上調至買入，並維持了6美元的目標股價。
NTGR: 31% | NETGEAR shares are trading higher after the company disclosed a settlement agreement with TP-Link Systems and raised its Q3 revenue guidance.
NTGR：31％ | NETGEAR的股價走高，此前該公司披露了與TP-Link Systems的和解協議，並提高了第三季度的收入預期。
FULC: -74% | Fulcrum Therapeutics' Phase 3 REACH Trial Of Losmapimod In Facioscapulohumeral Muscular Dystrophy Did Not Achieve Its Primary Endpoint Of Change From Baseline In Relative Surface Area With Losmapimod Compared To Placebo. In Addition, Secondary Endpoints Did Not Achieve Nominal Statistical Significance
FULC：-74% | Fulcrum Therapeutics對洛斯馬匹莫德治療面部肩肱肌萎縮症的3期REACH試驗並未實現其主要終點，即與安慰劑相比，洛斯馬匹莫德在相對錶面積上與基線相比的變化。此外，次要終點未達到名義統計學顯著性
譯文內容由第三人軟體翻譯。